You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 286 Tumor targeting and tissue biodistribution of RO7122290, a novel FAP-targeted 4–1BB (CD137) agonist, in patients with advanced solid tumors, using [89Zr]-RO7122290 as a PET tracer

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
286 Tumor targeting and tissue biodistribution of RO7122290, a novel FAP-targeted 4–1BB (CD137) agonist, in patients with advanced solid tumors, using [89Zr]-RO7122290 as a PET tracer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Garcia Velloso MJ, Penuelas I, Ponz-Sarvise M, et al
286 Tumor targeting and tissue biodistribution of RO7122290, a novel FAP-targeted 4–1BB (CD137) agonist, in patients with advanced solid tumors, using [89Zr]-RO7122290 as a PET tracer
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0286